November-December 2007 Copyright 2007, Track Your Plaque, LLC 

NOT A SUBSCRIBER YET?
Enter your e-mail address below and click the button for a
FREE SUBSCRIPTION
How did you hear about
Track Your Plaque?

 

 

Track Your Plaque shows how to use CT heart scans as the 1st step in a proven program to slow, stop, even REVERSE heart disease!

In this issue:

 

Hello, everybody!

When you think about it, the Track Your Plaque program is pretty darn simple.

Yes, our program begins with a simple heart scan. It does not require a CT angiogram, stress test, heart catheterization, or services of a hospital.

Yes, our program requires that you and your doctor have some acquaintance with the concepts of lipoprotein analysis. Relying on just cholesterol is a fool’s game. There are simply too many holes in cholesterol as a measure of heart disease risk. Control and reversal of heart disease is rarely possible just by paying attention only to cholesterol.

Yes, several supplements like fish oil, vitamin D, and niacin might be necessary. So will some specific, more rational, modifications of diet.

And, yes, in order to track your plaque, another heart scan will eventually be required. How else can you track results?

But compare the Track Your Plaque program to the conventional path: prescription drugs that yield limited benefits and plenty of side-effects, heart attack, major heart procedures like stents and bypass surgery. Which would you rather have: a 12-inch incision in your chest, a bill for $100,000, and a two month recovery—or a modest time and effort investment that allows you to conduct your life by your own rules?

I don’t know about you, but to me there is no choice: I’ll take the path of self-empowerment and prevention and reversal of heart disease any day

Track in health!


Dr. Davis
 


Another Track Your Plaque Success Story: It’s not brain surgery!

Richard is a successful 53-year old neurosurgeon. Deeply involved in his work, he neglected his health for the most part, aside from occasional efforts at exercise. His father’s death set him back, however, and Richard struggled with the loss of his father from heart disease. Richard grieved for several years until he finally decided to get himself a heart scan.

His heart scan score: 343, in the 99th percentile (worst 1%) for men in his age group. He was also mortified to discover that most of the plaque was in the upper portion of the left anterior descending artery, a location that a cardiologist colleague told him was the “widowmaker.”

No stranger to hospitals and procedures, Richard began to explore ways to avoid these paths. A friend of Richard’s told him about the Track Your Plaque program.

Quiet and bookish, we were pleasantly surprised at the religious adherence Richard showed in following the Track Your Plaque program. We first identified all hidden causes of coronary plaque, which included a severe excess of LDL particles (much higher than conventional LDL cholesterol suggested), 75% of which were small LDL; elevated IDL; lipoprotein(a); and—of course—severe deficiency of vitamin D3. Richard also showed pre-diabetic patterns of a high glucose, C-reactive protein, along with the small LDL pattern.

On the Track Your Plaque nutrition program, Richard lost 38 lbs, which alone yielded enormous improvements in lipoproteins. We added niacin, vitamin D, fish oil, and a low dose of a statin drug (along with coenzyme Q10).

18 months later, Richard’s heart scan score: 249, a 94 point or 27% drop.


Dr. Davis: Thankfully, despite his background in conventional medicine, Richard was willing to adopt some unconventional—but effective—new tools to gain control of his coronary plaque. Had he followed conventional advice (take Lipitor®, eat a low-fat diet), his score would undoubtedly have climbed to over 500.

Ironically, the radiologist who interpreted and scored Richard’s two heart scans was puzzled by the drop in score and simply declared that “with a value of 249, there is high cardiovascular risk.” Of course, followers of the Track Your Plaque program know that this is patently untrue. Richard’s risk for heart attack, given the substantial drop in heart scan score, is nearly zero.

Richard’s heroic weight loss, coupled with the Track Your Plaque approach of correcting all hidden causes, achieved what many still claim is impossible: substantial reduction of coronary atherosclerotic plaque and virtual elimination of heart attack risk.
 

Why be satisfied with deceleration?

In the Track Your Plaque program, we aim to stop or reduce your heart scan score.

Recall that, without any effort at prevention, heart scan scores can be expected to increase at the average rate of 30% per year.

I am continually surprised at how often people—that is, people not in the Track Your Plaque program—are often content with what I term "deceleration," or the slowing of plaque growth. In truth, most people are content with deceleration of plaque growth because they simply don't know that plaque continues to grow.

For instance, the BELLES Trial (Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES)), reported in 2005 showed that 650 women participants continued to increase heart scan scores 15% whether they took "high-intensity" statin therapy in the form of Lipitor®, 80 mg, or "low-intensity" statin therapy as pravastatin, 40 mg, even though the group taking Lipitor® experienced twice the amount of LDL reduction. In other words, heart scan scores continued to increase at the same rate of 15% per year regardless of the intensity of LDL lowering by statin drug.

Another study reported in 2006, Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial reported similar results. Of the 471 participants, those taking Lipitor®, 80 mg, per day experienced 27% per year plaque growth (LDL cholesterol 87 mg/dl); those taking 10 mg Lipitor® experienced 25% plaque growth (LDL 107 mg/dl). Once again, the intensity of statin therapy made no difference on the rate of plaque growth. Several other studies have documented a similar effect.

In other words, if we are content to sit back and take Lipitor® or other statin drug, follow the conventional American Heart Association low-fat, low-cholesterol diet, we will experience somewhere between 15 to 27% annual plaque growth—year after year. That can only result in catastrophe.

No wonder that conventional advice offered by your friendly neighborhood doctor will avoid (postpone?) only one heart attack in four.

Such is the nature of coronary plaque deceleration: growth is modestly slowed, but is not stopped. Nor is it reversed.

In the Track Your Plaque program, we grade deceleration of plaque growth into three distinct stages out of a total of five. (See Winning Your Personal War with Heart Disease: The Track Your Plaque 5 Stages of Success.)

Why be satisfied with deceleration? Why not aim for a total stop to plaque growth? Why not aim for stage 5 of Track Your Plaque success: Reversal!
 

Is heart disease a deficiency of statin drugs?

Judging from the conversations I hear from colleagues, the media, and drug company advertising, you'd think that heart disease has one cause: a deficiency of statin drugs.

As the thinking goes, if you have coronary disease, you need a statin drug (Lipitor®, Zocor®, Crestor®, Pravachol®, etc.). If you have progressive coronary disease, you need more statin drug. If you have a heart attack while on a statin drug, you need even more statin drug.

Some experts have even proposed that we do away with LDL cholesterol and just give everybody a statin drug at high doses, even put it in the water.

Does this make any sense to you?

Doesn't it make better sense that if someone has progressive heart disease or heart attack while on a statin drug, then target the other causes largely unaffected by a statin drug? There are at least a dozen major causes beyond LDL cholesterol, many of them untouched by statin drugs. Why not 1) identify them, then 2) correct them? It seems painfully obvious and simplistic, yet few people receive such obvious information for their heart disease prevention program.

Perhaps if LDL cholesterol remains high on a statin drug, then a higher dose is justified. But more often than not, it's not a high LDL on statin drugs that responsible, it's all the other causes.

Imagine someone has pneumonia. After 2 weeks of antibiotics, they are only partly better. The solution: a higher dose of the same antibiotic—but no question as to whether the antibiotic was the correct or complete solution in the first place. That's what happens in heart disease.

The medical community have been brainwashed into believing this $23 billion dollar per year bit of propaganda. The drug companies actively try to recruit the public into believing the same. Don't fall for it.

Statin drugs do indeed have a role. But they are not the complete answer. More of the same when disease progresses makes no sense at all. We all need to be smarter than that.

Tell a Friend About The FREE Track Your Plaque Newsletter

Friend's E-Mail Address:

Your E-Mail Address:      

Message to Your Friend:

 

Interested in becoming a Track Your Plaque Member?

If you’re interested in finding out more about becoming a Member of Track Your Plaque, go to the Track Your Plaque Member Benefits page. See why more and more people are finding out that there are alternatives to the conventional answers (or lack of answers!) for heart disease.

 

Track Your Plaque Members

Watch for our new and upcoming Special Reports on:

Phosphatidylcholine: Can it raise HDL?
The question of phosphatidylcholine (PC) and related supplements has arisen repeatedly in Track Your Plaque Forum discussions, as well as from our face-to-face experiences in the Track Your Plaque program. To date, phosphatidylcholine has not been an ingredient in our experience. However, interest is so great, and some of the anecdotal results so positive, that we decided to investigate further. Here is a discussion of the potential merits of this supplement, phosphatidylcholine, as a means of raising HDL cholesterol, possibly shifting its subclass distribution, as well as other lipid effects.


NEW FEATURE: Track Your Plaque Virtual Clinical Trials
 
 

Copyright 2007, Track Your Plaque